Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v4-EN
Language English English
Date Updated 2021-10-15 2021-10-05
Drug Identification Number 02401029 02401029
Brand name CEFAZOLIN FOR INJECTION, USP CEFAZOLIN FOR INJECTION, USP
Common or Proper name Cefazolin for Injection, USP 100 g SmartPak® Cefazolin for Injection, USP 100 g SmartPak®
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CEFAZOLIN CEFAZOLIN
Strength(s) 100G 100G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 100 g 100 g
ATC code J01DB J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-09-24 2021-09-24
Actual start date
Estimated end date 2021-10-14 2021-10-14
Actual end date 2021-10-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Cefazolin for Injection, USP 100 g SmartPak® effective September 24, 2021 until October 14, 2021.
Health Canada comments